Anti-CD38 CAR T cells demonstrated a potent anti-tumor effect when administered intravenously or intratumorally, thus suggesting that these cells efficiently migrate, infiltrate, and eliminate human MM tumors growing in their natural niche. The gene discussed is CD38; the disease is Miyoshi myopathy.